Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- EX-FILING FEES Filing Fee Table
- 3 Exhibit 3(I)(6)
- 3 Exhibit 3(I)
- 3 Exhibit 3(I)(2)
- 3 Exhibit 3(I)(3)
- 3 Exhibit 3(I)(4)
- 3 Exhibit 3(I)(5)
- 3 Exhibit 3(I)(6)
- 3 Exhibit 3(I)(7)
- 3 Exhibit 3(I)(8)
- 3 Exhibit 3(I)(9)
- 3 Exhibit 3(II)
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 10.9 Exhibit 10.9
- 10.10 Exhibit 10.10
- 10.15 Exhibit 10.15
- 14.1 Exhibit 14.1
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- Download Excel data file
- View Excel data file
Associated filings
- 23 May 24 424B3 Prospectus supplement
- 10 May 24 424B3 Prospectus supplement
- 29 Apr 24 424B3 Prospectus supplement
- 24 Apr 24 424B3 Prospectus supplement
- 9 Feb 24 424B3 Prospectus supplement
- 19 Jan 24 424B3 Prospectus supplement
- 20 Nov 23 424B3 Prospectus supplement
- 2 Oct 23 424B3 Prospectus supplement
- 2 Oct 23 EFFECT Notice of effectiveness
-
25 Sep 23 S-1 IPO registration
RGBP similar filings
Filing view
External links
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation in this Form S-1 of our report dated November 15, 2022, relating to the financial statements of Regen Biopharma, Inc. as of September 30, 2022 and 2021 and to all references to our firm included in this registration statement.
Certified Public Accountants
Lakewood, CO
September 21, 2023